ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS

被引：0
|
作者：
Tambasco, R. [1 ]
Gionchetti, P. [1 ]
Straforini, G. [1 ]
Brugnera, R. [1 ]
Calabrese, C. [1 ]
Poggioli, G. [1 ]
Laureti, S. [1 ]
Rizzello, F. [1 ]
Campieri, M. [1 ]
机构：
[1] Osped S Orsola Malpighi, Bologna, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2010年 / 42卷
关键词：
D O I：
10.1016/S1590-8658(10)60183-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P.70
引用
收藏
页码：S128 / S128
页数：1
相关论文
共 50 条
  • [1] Adalimumab in the Treatment of Perianal Crohn's Disease: A Single Center in 64 Patients
    Gionchetti, Paolo
    Rizzello, Fernando
    Tambasco, Rosy
    Straforini, Giulia
    Brugnera, Ramona
    Calabrese, Carlo
    Poggioli, Gilberto
    Laureti, Silvio
    Campieri, Massimo
    GASTROENTEROLOGY, 2010, 138 (05) : S328 - S328
  • [2] Adalimumab in the Treatment of Active Luminal and Perianal Crohn's Disease: A Single Center Experience in 100 Patients
    Rizzello, Fernando
    Gionchetti, Paolo
    Tambasco, Rosy
    Brugnera, Ramona
    Straforini, Giulia
    Calabrese, Carlo
    Campieri, Massimo
    GASTROENTEROLOGY, 2009, 136 (05) : A177 - A177
  • [3] Adalimumab in perianal Crohn's disease treatment: Experience of a tertiary center
    Carvalho, D.
    Bernardes, C.
    Russo, P.
    Saiote, J.
    Nunes, S.
    Ramos, J.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S258 - S259
  • [4] Adalimumab in the Treatment of Perianal Crohn's Disease: Short and Long Term Results in a Single Tertiary Center
    Rizzello, Fernando
    Calabrese, Carlo
    Calafiore, Andrea
    Laureti, Silvio
    Poggioli, Gilberto
    Campieri, Massimo
    Gionchetti, Paolo
    GASTROENTEROLOGY, 2012, 142 (05) : S358 - S358
  • [5] INFLIXIMAB VERSUS ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE
    Maas, Laura A.
    Limketkai, Berkeley N.
    Lazarev, Mark
    Melia, Joanna
    Selaru, Florin M.
    Parian, Alyssa M.
    GASTROENTEROLOGY, 2022, 162 (07) : S817 - S817
  • [6] The Safety and Efficacy of Adalimumab in Patients with Crohn's Disease: The Experience of a Single Tertiary Care Center
    Teriaky, Anouar
    Mosli, Mahmoud
    Gregor, Jamie
    Yan, Brian
    Ponich, Terry
    Chande, Nilesh
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S512 - S512
  • [7] Clinical experience with infliximab and adalimumab in a single-center cohort of patients with Crohn's disease
    Riis, Ase
    Martinsen, Tom C.
    Waldum, Helge L.
    Fossmark, Reidar
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (06) : 649 - 657
  • [8] ADALIMUMAB IS EFFECTIVE IN THE TREATMENT OF ACTIVE LUMINAL CROHN'S DISEASE AND MUCOSAL HEALING: A SINGLE CENTER EXPERIENCE IN 170 PATIENTS
    Tambasco, R.
    Gionchetti, P.
    Brugnera, R.
    Straforini, G.
    Calabrese, C.
    Liguori, G.
    Campieri, M.
    Rizzello, F.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S86 - S87
  • [9] Perianal Crohn's disease - Experience of a tertiary referral center
    Fernandes, S.
    Sousa, P.
    Moura, M.
    Correia, L.
    Goncalves, A. Rita
    Santos, P. Moura
    Valente, A.
    Baldaia, C.
    Velosa, J.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S230 - S230
  • [10] Side-Effects to Adalimumab - Single Center Real Life Experience in 111 Crohn's Disease Patients
    Zelinkova, Zuzana
    West, Rachel L.
    Bultman, Evelien
    van Liere-Baron, Astrid
    Mensink, Peter
    van der Woude, Christien J.
    GASTROENTEROLOGY, 2010, 138 (05) : S674 - S674
12345